Cargando…

Risk factors for rectal colonization of carbapenem-resistant Enterobacteriaceae in a tertiary care hospital: a case-control study from Turkey

BACKGROUND/AIM: This study aimed to evaluate the risk factors of patients colonized with carbapenem-resistant Enterobacteriaceae (CRE). MATERIALS AND METHODS: The study was conducted between January 2010 and March 2016. The colonized group consisted of patients who had a CRE strain in their rectal s...

Descripción completa

Detalles Bibliográficos
Autores principales:	ESER, Fatma, YILMAZ, Gül Ruhsar, GÜNER, Rahmet, HASANOĞLU, İmran, ÜRKMEZ KORKMAZ, Fatma Yekta, AÇIKGÖZ, Ziya Cibali, TAŞYARAN, Mehmet Akın
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350833/ https://www.ncbi.nlm.nih.gov/pubmed/30761851 http://dx.doi.org/10.3906/sag-1810-65

Ejemplares similares

Tenofovir disoproxil fumarate may not cause renal and bone toxicity in chronic hepatitis B patients: a retrospective cross-sectional study
por: GÜNER, Rahmet, et al.
Publicado: (2019)

Comparison of Antibiotic Regimens in Intra-abdominal Infections
por: Hasanoglu, Imran, et al.
Publicado: (2017)

Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study
por: Yilmaz, Gul R., et al.
Publicado: (2016)

Investigation of the relation between risk assessment of exposure and nosocomial SARS-CoV-2 transmission in healthcare workers: a prospective single-centre study
por: Kaya Kalem, Ayse, et al.
Publicado: (2022)

Effect of 2 Different High-Dose Methylprednisolone Treatments on Clinical Outcomes in Severe COVID-19 Patients
por: Eser, Fatma, et al.
Publicado: (2023)

COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity
por: Sezer, Sevilay, et al.
Publicado: (2022)

Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
por: Tütüncü, Emin Ediz, et al.
Publicado: (2017)

COVID-19: Prevention and control measures in community
por: GÜNER, Rahmet, et al.
Publicado: (2020)

Evaluating the efficiency of public policy measures against COVID-19
por: GÜNER, Rahmet, et al.
Publicado: (2021)

Do Lifestyle Changes of Renal Transplant Recipients During the Pandemic Reduce the Risk of Coronavirus Disease 2019?
por: Hasanoglu, Imran, et al.
Publicado: (2020)

A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol
por: Kalem, Ayse Kaya, et al.
Publicado: (2021)

COVID-19 experience of the major pandemic response center in the capital: results of the pandemic’s first month in Turkey
por: GÜNER, Rahmet, et al.
Publicado: (2020)

Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg
por: Hasanoglu, Imran, et al.
Publicado: (2020)

532. Can Saccharomyces boulardii Therapy Be Effective in Decolonizing Rectal Carbapenem-Resistant Enterobacteriaceae (CRE) Colonization?
por: Resat Sipahi, Oguz, et al.
Publicado: (2019)

Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae: A Menace to Highly Vulnerable Patients
por: Kumar, Amarjeet, et al.
Publicado: (2018)

Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey
por: Baran, Irmak, et al.
Publicado: (2016)

The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey
por: Karabay, Oguz, et al.
Publicado: (2016)

Carbapenem Resistant Enterobacteriaceae infections in Houston, Texas: An outline
por: Rehman, Hafeez, et al.
Publicado: (2017)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study
por: Chu, Wenwen, et al.
Publicado: (2022)

Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates
por: Sahin, Kazım, et al.
Publicado: (2015)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Role of rapid antibody and ELISA tests in the evaluation of serological response in patients with SARS-CoV-2 PCR positivity
por: Cosgun, Yasemin, et al.
Publicado: (2021)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
por: Korach-Rechtman, Hila, et al.
Publicado: (2020)

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae
por: Armin, Shahnaz, et al.
Publicado: (2023)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

The additional contribution of second nasopharyngeal PCR to COVID-19 diagnosis in patients with negative initial test
por: Kayaaslan, B., et al.
Publicado: (2021)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

The Infinity War: How to Cope with Carbapenem-resistant Enterobacteriaceae
por: Yoo, Jin-Hong
Publicado: (2018)

Comparison of clinical methods for detecting carbapenem-resistant Enterobacteriaceae
por: Kost, Kirsten, et al.
Publicado: (2017)

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
por: Suay-García, Beatriz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gnh75g78f398udfib0aafr7qls